USP21 (NM_012475) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC210554L3V
- LentiORF®
Lenti ORF particles, USP21 (Myc-DDK tagged) - Human ubiquitin specific peptidase 21 (USP21), transcript variant 1, 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
货期*
详询
规格
Product images
经常一起买 (3)
Specifications
Product Data | |
Product Name | USP21 (NM_012475) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | USP16; USP23 |
Vector | pLenti-C-Myc-DDK-P2A-Puro |
ACCN | NM_012475 |
ORF Size | 1695 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC210554).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_012475.4 |
RefSeq Size | 2217 bp |
RefSeq ORF | 1698 bp |
Locus ID | 27005 |
Domains | UCH |
Protein Families | Druggable Genome, Protease |
MW | 62.5 kDa |
Gene Summary | This gene encodes a member of the C19 peptidase family, also known as family 2 of ubiquitin carboxy-terminal hydrolases. The encoded protein cleaves ubiquitin from ubiquitinated proteins for recycling in intracellular protein degradation. The encoded protein is also able to release NEDD8, a ubiquitin-like protein, from NEDD8-conjugated proteins. This gene has been referred to as USP16 and USP23 but is now known as USP21. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2016] |
Documents
Product Manuals |
FAQs |
SDS |
Resources
You may also need
Customer
Reviews
Loading...